Miralem T, Wang A, Whiteside C I, Templeton D M
Department of Clinical Biochemistry, University of Toronto, Toronto, Canada.
J Biol Chem. 1996 Jul 19;271(29):17100-6. doi: 10.1074/jbc.271.29.17100.
Heparin suppresses mitogenic responses in renal mesangial cells, and when quiescent mesangial cells are stimulated with serum, heparin blocks the induction of c-fos seen at 15 min. Because heparin is taken up by cells over a much longer time course, we addressed mechanisms whereby extracellular heparin might suppress c-fos induction at such early times. Quiescent cells were treated with serum, 12-O-tetradecanoylphorbol-13-acetate, or low concentrations of Ca2+ ionophores that produced increases in intracellular Ca2+ concentration ([Ca2+]i) in the physiological range. Each treatment caused an increase in c-fos mRNA, but they did so by different mechanisms. Serum activated mitogen-activated protein kinase (MAPK) and increased [Ca2+]i without affecting protein kinase C. Activation of protein kinase C with phorbol ester activated MAPK without much effect on [Ca2+]i. Ionophores increased [Ca2+]i without affecting basal levels of protein kinase C or MAPK. Heparin (1 microg/ml) suppressed the induction of c-fos initiated by all three treatments. It did not affect the activity of protein kinase C, but inhibited activation of MAPK by either serum or phorbol ester, suggesting a common site of action at or below the probable convergence of the induced signals at Ras/Raf-1 activation. Heparin also inhibited the serum-stimulated entry of extracellular Ca2+ to the same extent as verapamil, consistent with the ability of verapamil to block L-type Ca2+ channels and the known presence of these channels in mesangial cells. However, this effect does not appear to be related to heparin's ability to inhibit induction of c-fos. First, verapamil had no effect on induction of c-fos by serum. Second, heparin had no effect on changes in [Ca2+]i achieved by ionophores. We conclude that heparin suppresses induction of c-fos in mesangial cells by blocking at least two different points in signal transduction cascades, one upstream of MAPK and the other independent of MAPK, but dependent on intracellular Ca2+.
肝素可抑制肾系膜细胞的有丝分裂反应,当静止的系膜细胞受到血清刺激时,肝素可阻断15分钟时出现的c-fos诱导。由于细胞摄取肝素的时间过程长得多,我们探讨了细胞外肝素在如此早期阶段抑制c-fos诱导的机制。用血清、12-O-十四烷酰佛波醇-13-乙酸酯或低浓度的钙离子载体处理静止细胞,这些处理可使细胞内钙离子浓度([Ca2+]i)在生理范围内升高。每种处理均导致c-fos mRNA增加,但它们的作用机制不同。血清激活丝裂原活化蛋白激酶(MAPK)并增加[Ca2+]i,而不影响蛋白激酶C。佛波酯激活蛋白激酶C可激活MAPK,而对[Ca2+]i影响不大。离子载体增加[Ca2+]i,而不影响蛋白激酶C或MAPK的基础水平。肝素(1微克/毫升)抑制了所有三种处理引发的c-fos诱导。它不影响蛋白激酶C的活性,但抑制血清或佛波酯对MAPK的激活,提示在Ras/Raf-1激活时诱导信号可能汇聚点或其以下存在共同作用位点。肝素还抑制血清刺激的细胞外Ca2+内流,其程度与维拉帕米相同,这与维拉帕米阻断L型Ca2+通道的能力以及系膜细胞中已知存在这些通道一致。然而,这种作用似乎与肝素抑制c-fos诱导的能力无关。首先,维拉帕米对血清诱导的c-fos无影响。其次,肝素对离子载体引起的[Ca2+]i变化无影响。我们得出结论,肝素通过阻断信号转导级联中的至少两个不同点来抑制系膜细胞中c-fos的诱导,一个在MAPK上游,另一个独立于MAPK,但依赖于细胞内Ca2+。